600+ Healthcare Leaders Already Committed. Here's Who's Joining Them.

By: Women's HealthX Editorial
09/02/2026

Boston, MA -- September 3 2026:  As healthcare organizations continue to evaluate where to invest their time, budget, and attention, one question comes up repeatedly:

Who will actually be in the room?

With Women's HealthX approaching this December, the answer is becoming increasingly clear. Already almost 700 healthcare professionals have committed to attend, bringing together leaders from health plans, providers, employers, life sciences organizations, government agencies, research institutions, and healthcare innovators.

More importantly, this is a senior audience.

Please note: this information is up-to-date as of September 1 2026 - it will change week to week until the event in December 3-4.

A room full of decision-makers


C-Suite & Founders (18%)

VPs & Global Leaders (28%)

Directors & Department Heads (34%)

Other Seniorities (20%)

``

Current attendee data shows:

  • 80% are Director level or above
  • 18% are C-suite executives or founders
  • 28% are Vice Presidents or Global Leaders
  • 34% are Directors or Department Heads
  • See the list

In other words, the conversations taking place at Women's HealthX will be shaped by the people responsible for making decisions, allocating resources, and driving change across healthcare.

A very healthy ratio of industry vs solution providers


600+

Industry Professionals (74%)

Solution Providers (26%)

Another standout trend is the composition of the audience itself.

Currently: 74% of attendees are industry professionals meaning 26% are commercial solution providers - see the list here.

That means the majority of attendees represent organizations actively delivering, funding, purchasing, supporting, or shaping healthcare.

A cross-sector conversation

Women's HealthX has been designed to bring together stakeholders who rarely have the opportunity to engage with each other in the same room.

Confirmed faculty and attendees include representatives from:

  • FDA
  • CVS Health
  • Humana
  • Elevance Health
  • BlueCross BlueShield of Tennessee
  • Novartis
  • Beth Israel Deaconess
  • Point32Health
  • EMD Serono
  • Eli Lilly
  • Mount Sinai Health System
  • Takeda
  • Gilead
  • WellSpan Health
  • Corewell Health
  • Mass General Brigham

and many more.

Together, these organizations represent perspectives spanning healthcare delivery, reimbursement, workforce strategy, research, innovation, and women's health policy.

Why it matters

The biggest challenges in women's health cannot be solved by any one stakeholder group acting alone.

Whether the focus is maternal health, menopause, chronic disease, workforce wellbeing, access, evidence generation, or care delivery, progress depends on collaboration across the healthcare ecosystem.

Women's HealthX has been built to facilitate exactly those conversations. With more than 600 attendees already committed and a strong majority of end-user participation, the event is shaping up to be one of the most senior and cross-functional gatherings dedicated to women's health in the United States. 

Want to see who's already attending? 

Women’s HealthX 2026 | From Rhetoric to Results

Encore Boston Harbor | December 3-4 2026

Bypass abstract market rhetoric to evaluate real-world health economics, regulatory compliance mandates, and care delivery systems. Join the region's foremost health plan medical directors, hospital COOs, biopharma innovators, and enterprise benefits buyers anchoring our 2026 tracks.